Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Cor.../ US4579852082 /
IART
|
2024-04-19 4:31:43 PM
|
Chg.
-0.8800
|
Volume |
Bid4:31:52 PM |
Ask4:31:52 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
30.7500USD
|
-2.78%
|
204,462
Turnover: 4.98 mill. |
30.7300Bid Size: 100 |
30.7600Ask Size: 200 |
2.44 bill.USD |
- |
36.74 |
Business description
Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for caregivers, so they can concentrate on providing the best patient care. Integra offers innovative solutions, including leading regenerative technologies, in specialty surgical solutions and orthopedics and tissue technologies.
Management board & Supervisory board
| CEO |
| Jan De Witte |
| Management board |
| Carrie Anderson, Andrea Caruso, Dr. Kenneth Burhop, Eric Schwartz, Glenn G. Coleman, Judith E. O'Grady, Lisa Evoli, Michael McBreen, Robert T. Davis Jr., Sravan K. Emany, Steve Leonard, Susan Krause, William Compton |
| Supervisory board |
| Dr. Stuart M. Essig, Barbara B. Hill, Christian S. Schade, Dr. Donald E. Morel, Jr., Dr. Keith Bradley, Peter J. Arduini, Raymond G. Murphy, Rhonda Germany Ballintyn, Shaundra D. Clay |
Company data
| Name: |
Integra LifeSciences Holdings Corp. |
| Address: |
1100 Campus Road,Plainsboro, New Jersey 08540, USA |
| Phone: |
+1-609-275-0500 |
| Fax: |
+1-609-275-5363 |
| E-mail: |
custsvcnj@integralife.com
|
| Internet: |
www.integralife.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
38.60% |
| IPO date: |
- |
Investor relations
| Name: |
Michael Beaulieu |
| IR phone: |
+1-609-936-2268 |
| IR Fax: |
- |
| IR e-mail: |
ir@integralife.com
|
Main Shareholders
| Freefloat |
|
38.60% |
| Tru St Partnership LP and Provco Leasing |
|
11.70% |
| Wellington Management Group LLP |
|
11.40% |
| Capital Research & Management Co. |
|
9.80% |
| The Vanguard Group |
|
7.70% |
| Champlain Investment Partners, LLC |
|
7.70% |
| BlackRock, Inc. |
|
7.60% |
| Janus Henderson Group plc 201 |
|
5.50% |
